Drugs / TMZ
last change Jun 2020 re-read 2 minutes ago

TMZ

Developed for
glioblastoma
Investigated by
Annias Immunotherapeutics, Inc. · Eric Thompson, M.D. · National Cancer Institute (NCI) · National Institutes of Health (NIH)

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02864368 Dec 2016 → Jun 2020 glioblastoma Eric Thompson, M.D. Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TMZ ClinicalTrials.gov intervention name — accepted as the source's own label NCT02864368